Double maintains 1 strategies that include NUVL - Nuvalent, Inc.
Current Value
$81.301 Year Return
Current Value
$81.301 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 49.48% | $5.92B | 0.35% |
PTH | 48.18% | $125.48M | 0.6% |
IBB | 47.12% | $6.33B | 0.45% |
FBT | 43.82% | $1.15B | 0.56% |
IWO | 42.51% | $12.47B | 0.24% |
GNOM | 41.93% | $65.99M | 0.5% |
ISCG | 41.81% | $665.64M | 0.06% |
XPH | 41.60% | $164.02M | 0.35% |
PBE | 41.50% | $245.59M | 0.58% |
ARKG | 41.47% | $1.19B | 0.75% |
VBK | 41.03% | $20.12B | 0.07% |
VTWO | 40.74% | $11.72B | 0.07% |
VXF | 40.61% | $22.36B | 0.05% |
SCHA | 40.48% | $18.63B | 0.04% |
IWM | 40.45% | $72.71B | 0.19% |
AOR | 40.42% | $2.24B | 0.15% |
IWC | 40.34% | $956.01M | 0.6% |
KJAN | 39.93% | $354.50M | 0.79% |
TMSL | 39.92% | $504.97M | 0.55% |
AOM | 39.78% | $1.45B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CAG | -0.04% | $11.92B | -8.06% | 5.58% |
FDP | -0.07% | $1.48B | +27.40% | 3.22% |
DOGZ | -0.13% | $429.53M | +745.61% | 0.00% |
LUMN | 0.23% | $4.78B | +194.38% | 0.00% |
JBLU | -0.24% | $2.32B | -6.70% | 0.00% |
ADM | -0.30% | $21.87B | -15.83% | 3.27% |
AGL | 0.31% | $1.43B | -52.07% | 0.00% |
CLX | 0.36% | $18.57B | -1.34% | 3.24% |
MNOV | -0.47% | $91.72M | +38.52% | 0.00% |
AVAV | -0.47% | $4.55B | +27.51% | 0.00% |
IMMP | 0.48% | $283.84M | -15.22% | 0.00% |
PULM | 0.49% | $27.36M | +307.07% | 0.00% |
NOC | 0.72% | $65.87B | +1.12% | 1.79% |
GERN | 0.76% | $1.69B | +33.49% | 0.00% |
MSDL | -0.80% | $1.83B | +1.54% | 9.68% |
IMNN | -0.85% | $13.05M | +69.81% | 0.00% |
LMT | 0.86% | $102.33B | +2.74% | 2.95% |
HSY | 0.91% | $32.54B | -16.50% | 3.43% |
LTM | -0.92% | $9.87B | -100.00% | <0.01% |
NNVC | 0.93% | $18.51M | +8.40% | 0.00% |
SeekingAlpha
Nuvalent, Inc. shares have fallen approximately 30% after promising updates on its two lead NSCLC candidates rallied the stock to all-time highs. Read the full report on the stock here.
Finnhub
CAMBRIDGE - Nuvalent, Inc. , a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today highlighted pipeline...
SeekingAlpha
Nuvalent's NVL-655 and Zidesamtinib show strong potential as first-line therapies for NSCLC, with impressive Phase I/II trial results. Read my NUVL thesis.
Finnhub
Headlines that Matter for Companies and Executives in Regulated Industries California Doctor to Pay $3 Million for Insider Trading On December 18, a California oncologist agreed to pay the US...
Yahoo
American Air upgraded, Nordstrom downgraded: Wall Street's top analyst calls
Yahoo
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 9:00 a.m. PT in San Francisco.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BMRN | -16.37% | $12.28B | -27.04% | 0.00% |
FENG | -9.18% | $13.42M | +68.97% | 0.00% |
LRN | -9.17% | $6.07B | +132.82% | 0.00% |
TCTM | -8.46% | $3.66M | -59.28% | 0.00% |
CBOE | -8.16% | $21.80B | +11.92% | 1.14% |
ITOS | -7.06% | $265.60M | -27.81% | 0.00% |
STG | -6.92% | $35.60M | -18.31% | 0.00% |
K | -6.82% | $28.34B | +48.42% | 2.75% |
NXTC | -6.72% | $20.29M | -48.61% | 0.00% |
TKC | -6.46% | $6.54B | +37.43% | 2.77% |
PEP | -6.15% | $198.29B | -13.87% | 3.66% |
HUSA | -6.09% | $22.27M | -3.40% | 0.00% |
NEUE | -5.55% | $60.60M | -12.39% | 0.00% |
LITB | -5.17% | $18.75M | -83.65% | 0.00% |
KDP | -5.07% | $43.23B | +2.51% | 2.77% |
CPSH | -5.02% | $28.91M | -18.44% | 0.00% |
BTCT | -4.51% | $27.54M | +40.15% | 0.00% |
LFVN | -4.45% | $231.45M | +184.13% | 0.85% |
WOW | -4.26% | $378.94M | +26.99% | 0.00% |
NUS | -4.23% | $319.14M | -53.55% | 2.57% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -30.59% | $277.56M | 1.43% |
VIXY | -22.59% | $195.31M | 0.85% |
UUP | -20.53% | $389.72M | 0.77% |
USDU | -18.22% | $282.00M | 0.5% |
WEAT | -17.67% | $125.72M | 0.28% |
TAIL | -14.37% | $62.82M | 0.59% |
CTA | -12.57% | $681.78M | 0.76% |
TPMN | -12.31% | $34.10M | 0.65% |
KCCA | -8.28% | $102.53M | 0.87% |
XHLF | -6.28% | $1.07B | 0.03% |
USFR | -6.16% | $17.58B | 0.15% |
TFLO | -5.21% | $6.53B | 0.15% |
DBA | -4.99% | $897.78M | 0.93% |
GBIL | -4.92% | $5.76B | 0.12% |
UNG | -4.89% | $739.12M | 1.06% |
KRBN | -3.74% | $192.93M | 0.85% |
FLRN | -3.31% | $2.62B | 0.15% |
TBLL | -3.28% | $2.04B | 0.08% |
FLOT | -2.32% | $8.45B | 0.15% |
FLTR | -2.25% | $2.14B | 0.14% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ULST | -0.29% | $558.12M | 0.2% |
BIL | -0.36% | $37.22B | 0.1356% |
SOYB | 0.41% | $27.79M | 0.22% |
CLOI | -0.64% | $911.21M | 0.4% |
BSSX | 0.69% | $69.62M | 0.18% |
SGOV | -0.74% | $33.82B | 0.09% |
CORN | -0.82% | $65.57M | 0.2% |
SPYT | 1.24% | $105.75M | 0.94% |
BILZ | -1.44% | $760.23M | 0.14% |
AGZD | -1.90% | $135.16M | 0.23% |
DBE | 1.92% | $56.04M | 0.77% |
CLOA | -2.07% | $710.77M | 0.2% |
FLTR | -2.25% | $2.14B | 0.14% |
FLOT | -2.32% | $8.45B | 0.15% |
KMLM | 2.41% | $327.00M | 0.9% |
BNO | 2.71% | $94.01M | 1% |
DBO | 2.96% | $191.98M | 0.77% |
TBLL | -3.28% | $2.04B | 0.08% |
FLRN | -3.31% | $2.62B | 0.15% |
CCOR | 3.52% | $71.02M | 1.18% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KYMR | 40.10% | $2.37B | -2.11% | 0.00% |
ASND | 37.70% | $8.52B | -3.20% | 0.00% |
IDYA | 36.96% | $1.79B | -55.30% | 0.00% |
OPEN | 35.44% | $1.07B | -55.22% | 0.00% |
IGMS | 34.96% | $81.47M | -91.10% | 0.00% |
SYNA | 34.77% | $2.85B | -33.91% | 0.00% |
DNLI | 34.54% | $3.07B | +16.07% | 0.00% |
FATE | 34.43% | $144.65M | -82.06% | 0.00% |
CRNX | 33.80% | $3.27B | -4.50% | 0.00% |
BN | 33.05% | $91.08B | +48.98% | 0.52% |
BNT | 32.83% | $7.76B | +49.25% | 0.00% |
CCS | 32.83% | $2.22B | -19.34% | 1.44% |
AVXL | 32.83% | $718.39M | +45.28% | 0.00% |
DMRC | 32.68% | $743.30M | -12.26% | 0.00% |
BLD | 32.50% | $9.65B | -17.30% | 0.00% |
NRIX | 32.49% | $1.33B | +78.38% | 0.00% |
ZG | 32.47% | $17.61B | +35.05% | 0.00% |
Z | 32.47% | $18.38B | +35.89% | 0.00% |
MHO | 32.44% | $3.21B | -5.46% | 0.00% |
BX | 32.39% | $194.38B | +23.21% | 2.43% |